Switzerland’s Novartis to inject $100 million into malaria drug research

Switzerland’s Novartis to inject $100 million into malaria drug research

Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016.

Ebola worries offset malaria gains: WHO

Ebola worries offset malaria gains: WHO

Film writer Curtis makes Geneva malaria appeal

Film writer Curtis makes Geneva malaria appeal